Julie A. Bentz
Known title: DirectorCIK: 0001887410
Associated companies
Transaction History
| AVA | ▲ Buy | Grant | 3,538 | $145K | 5/8/2026 | View on chart |
| AVA | ▲ Buy | Grant | 91 | $3K | 9/2/2025 | View on chart |
| AVA | ▲ Buy | Grant | 3,232 | $135K | 5/5/2025 | View on chart |
| AVA | ▲ Buy | Grant | 43 | $2K | 9/3/2024 | View on chart |
| AVA | ▲ Buy | Grant | 3,533 | $130K | 5/3/2024 | View on chart |
| AVA | ▲ Buy | Grant | 50 | $2K | 9/1/2023 | View on chart |
| AVA | ▲ Buy | Grant | 2,839 | $125K | 5/15/2023 | View on chart |
| AVA | ▲ Buy | Grant | 123 | $5K | 9/1/2022 | View on chart |
| AVA | ▲ Buy | Grant | 2,564 | $110K | 5/16/2022 | View on chart |
| AVA | ▲ Buy | Grant | 795 | $32K | 11/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Avista (AVA) Faces Barclays downgrade and upcoming earnings call
Barclays kept an equal‑weight rating on Avista but cut its price target to $35, indicating a more cautious view. The company announced the date for its third‑quarter 2026 earnings conference call, which may provide further insight into performance. A recent Yahoo analysis highlighted the stock’s potential upside relative to its risk profile, noting its dividend yield and valuation. These items come as the stock trades near its recent support level.
Avista (AVA) Faces Barclays downgrade and upcoming earnings call. Barclays kept an equal‑weight rating on Avista but cut its price target to $35, indicating a more cautious view. The company announced the date for its third‑quarter 2026 earnings conference call, which may provide further insight into performance. A recent Yahoo analysis highlighted the stock’s potential upside relative to its risk profile, noting its dividend yield and valuation. These items come as the stock trades near its recent support level.